Freteluco v. Smith's Food and Drug Centers, Inc.

District Court, D. Nevada·Decided January 8, 2021·No. 2:19-cv-00759·Unknown

Opinion

* * *

ANNA MARIE FRETELUCO, Case No. 2:19-cv-00759-JCM-EJY

Plaintiff,

v. ORDER

INC., a foreign corporation; DOES 1-10; ROE CORPORAITONS 1-10; inclusive,

Defendants.

Pending before the Court is Plaintiff’s Motion to Strike/Exclude Defendant’s Expert Lewis M. Etcoff, Ph.d. (ECF No. 52), the Response to Plaintiff’s Motion to Strike/Exclude Defendant’s Expert Lewis M. Etcoff, Ph.d. (ECF No. 58), and Plaintiff’s Reply in Support of her Motion to Strike/Exclude Defendant’s Expert Lewis M. Etcoff, Ph.d. (ECF No. 61). I. Background On April 20, 2020, at a hearing on two motions (see Transcript at ECF No. 36), and on June 29, 2020, on a written order (ECF No. 46), the Court Ordered and affirmed that the discovery period was reopened for a 90 day period allowing Defendant time to retain and disclose rebuttal experts and an Independent Medical Examination (“IME”) pursuant to Fed. R. Civ. P. 35. Dr. Lewis Etcoff was originally designated by Defendant as an IME pursuant to Rule 35 for purposes of his proposed neuropsychological examination of Plaintiff. ECF Nos. 40 and 44. On July 20, 2020, Defendant timely disclosed and produced a report from Dr. Etcoff identifying him as a rebuttal expert. ECF No. 48-3 at 2-33.1 In response to Plaintiff’s instant Motion to Strike, Defendant again identified Dr. Etcoff as a “rebuttal expert.” ECF No. 58. This distinction is important because Plaintiff’s Motion to exclude Dr. Etcoff is based on the premise that, as a rebuttal expert, Dr. Etcoff’s testimony must be limited to contradicting or rebutting evidence presented by an initially disclosed expert. ECF No. 52 at 6 (and citations therein). Thus, Plaintiff avers that Dr. Etcoff cannot rebut any diagnosis or opinions given by Plaintiff’s treating physician Dr. Fazzini because Dr. Fazzini was not designated as either a retained or non-retained expert pursuant to Fed. R. Civ. P. 26(2)(B) or (C). ECF No. 52 at 7-8. Plaintiff further argues that Dr. Etcoff cannot be offered to rebut any opinions offered by Dr. Roitman, who was designated as a retained expert, because Dr. Roitman offered no opinion on Plaintiff’s psychiatric diagnosis. ECF Nos. 48-1 at 15 and 52 at 8.2 Plaintiff’s Initial Expert Disclosures states that Dr. Roitman “will testify as a retained treating expert in his capacity as a medical physician who provided medical care to Plaintiff, [sic] following the subject fall.” ECF No. 48-1 at 15. The disclosure goes on to state that Dr. Roitman (misidentified as Dr. Garber at id.) will “give expert opinions regarding the treatment of Plaintiff, the necessity of the treatment rendered, the causation of the necessity for past and future medical treatment, his expert opinion as to past and future restrictions of activities, including work activities, caused by the fall, … the cost of past and future medical care and whether those medical costs fall within the ordinary and customary charges for similar medical care and treatment, and whether Plaintiff has a diminished work life expectancy, work capacity, and/or life expectancy as a result of the fall.” Id. Plaintiff attached a single page letter written by Dr. Roitman to Plaintiff’s counsel, dated December 15, 2019, to her Initial Expert Disclosure. ECF No. 48-2 at 3. As explained below, this disclosure does not meet the requirements of Fed. R. Civ. P. 29(a)(2)(B) for retained experts. Nevertheless, Dr. Roitman’s letter states, in pertinent part, that:

[b]ased on Ms. Freteluco’s history and mental status examination, she hasn’t been doing well. … As she presents, Ms. Freteluco’s symptoms can be explained as

Free access — add to your briefcase to read the full text and ask questions with AI

Freteluco v. Smith's Food and Drug Centers, Inc., (D. Nev. 2021).

Freteluco v. Smith's Food and Drug Centers, Inc. (Freteluco v. Smith's Food and Drug Centers, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related